Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review

doi:10.3748/wjg.v26.i3.353

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9459)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

1122

WORD

152

HTML

5796

Figures (1-2)

289

Tables (1-3)

257

Sum=7616

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

750

Download

1093

Sum=1843

Jan 21, 2020 (publication date) through May 15, 2024

Times Cited of This Article

Times Cited (54)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Gastroenterol. Jan 21, 2020; 26(3): 353-365
Published online Jan 21, 2020. doi: 10.3748/wjg.v26.i3.353

Open in New Tab Full Size Figure Download Figure

Figure 1 PRISMA 2009 Flow diagram describing the selection of the studies reporting programmed cell death-1 inhibitor-related cholangitis for our review.

Open in New Tab Full Size Figure Download Figure

Figure 2 Our cases with sclerosing cholangitis caused by nivolumab (Case 29, A–C; Case 30, D–F; Case 31, G–J). A, D: Computed tomography; G, H: Magnetic resonance imaging; B, E, I: Endoscopic ultrasonography. Revealed diffuse hypertrophy of biliary tract (yellow allows) in all cases. C, F: Endoscopic retrograde cholangiopancreatography revealed biliary stenosis of the intrahepatic bile duct (arrow-head) in Case 30. J: In Case 31, liver biopsy showed lymphocyte infiltration in Glisson’s capsule (black arrow).

Citation: Onoyama T, Takeda Y, Yamashita T, Hamamoto W, Sakamoto Y, Koda H, Kawata S, Matsumoto K, Isomoto H. Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review. World J Gastroenterol 2020; 26(3): 353-365
URL: https://www.wjgnet.com/1007-9327/full/v26/i3/353.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i3.353